Delivery of RNA interference

被引:162
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [41] MEDI 27-Systemic delivery of RNA interference for metabolic and oncology targets
    Manoharan, Muthiah
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [42] Delivery Systems for RNA Interference-Based Therapy and Their Applications Against Cancer
    Liu, Tingting
    Wang, Liping
    Xin, Hongchuan
    Jin, Lili
    Zhang, Dianbao
    SCIENCE OF ADVANCED MATERIALS, 2020, 12 (01) : 75 - 86
  • [43] Delivery systems for the direct application of siRNAs to induce RNA interference (RNAi) in vivo
    Aigner, Achim
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2006,
  • [44] Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability
    Maguregui, Ander
    Abe, Hiroshi
    CHEMBIOCHEM, 2020, 21 (13) : 1808 - 1815
  • [45] Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle
    Lasser, Cecilia
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (01) : 103 - 117
  • [46] Retroviral delivery of RNA interference against Marek's disease virus in vivo
    Chen, M.
    Payne, W. S.
    Dunn, J. R.
    Chang, S.
    Zhang, H. M.
    Hunt, H. D.
    Dodgson, J. B.
    POULTRY SCIENCE, 2009, 88 (07) : 1373 - 1380
  • [47] NORMOTHERMIC MACHINE PERFUSION FACILITATES DELIVERY OF RNA INTERFERENCE THERAPEUTICS IN DONOR KIDNEYS
    Thompson, Emily
    Sewpaul, Avinash
    Figuereido, Rodrigo
    Ferdinand, John
    Bates, Lucy
    Tingle, Sam
    Connelly, Chloe
    Hosgood, Sarah
    Nicholson, Michael
    Clatworthy, Menna
    Ali, Simi
    Wilson, Colin
    Sheerin, Neil
    TRANSPLANT INTERNATIONAL, 2021, 34 : 154 - 155
  • [48] Formulation of RNA interference-based drugs for pulmonary delivery: challenges and opportunities
    Thanki, Kaushik
    Blum, Kevin G.
    Thakur, Aneesh
    Rose, Fabrice
    Foged, Camilla
    THERAPEUTIC DELIVERY, 2018, 9 (10) : 731 - 750
  • [49] Application of Carbon Nanomaterials in Gene Delivery for Endogenous RNA Interference In Vitro and In Vivo
    Li, Lanying
    Wen, Yanli
    Xu, Qin
    Xu, Li
    Liu, Dong
    Liu, Gang
    Huang, Qing
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (22) : 3191 - 3198
  • [50] Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
    Li, Shyh-Dar
    Huang, Leaf
    MOLECULAR PHARMACEUTICS, 2006, 3 (05) : 579 - 588